http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64818e1de88cd196a00b2205cbb21603
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Neal |
| name | David E Neal David E. Neal |
| given-name | David E. David E |
| organization-name | 49Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.; 50Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK. 6Oncology Centre, Addenbrooke’s Hospital, Cambridge; and Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom; Division of Urology, Department of Surgery and Cambridge Urology Translational Research and Clinical Trials Office, Cambridge, United Kingdom Authors' Affiliations: 1School of Social and Community Medicine and 2MRC Centre for Causal Analysis in School of Social and Community Medicine of Bristol, Bristol, United Kingdom; 3Department of Pharmacology, University of Oxford; 4Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom; 5Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway; 6Institute for Cancer Studies, University of Sheffield, Sheffield, United Kingdom; and 7Department of Oncology, University of Cambridge, Cambridge, United Kingdom Surgical Oncology (Uro‐Oncology: S4) University of Cambridge Addenbrooke's Hospital Cambridge UK; Cancer Research UK Cambridge Research Institute Cambridge UK CRUK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, U.K. CRUK-Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, United Kingdom Cambridge University Department of Urology Addenbrooke's Hospital and Cancer Research UK (CRUK) Cambridge Institute Cambridge UK University Department of Surgery and Gastroenterology Unit, The General Infirmary, Leeds LSl 3EX Department of Oncology, University of Cambridge, Cambridge, United Kingdom Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK Nuffield Department of Surgery University of Oxford Oxford United Kingdom; Surgical Oncology (Uro‐Oncology: S4), University of Cambridge Box 279, Addenbrooke's Hospital, Hills Road Cambridge United Kingdom Nuffield Department of Surgical Sciences, University of Oxford, Oxford, England; Department of Oncology, Addenbrooke’s Hospital, University of Cambridge, Cambridge, England 1Department of Social Medicine, University of Bristol, Canynge Hall and 2MRC Centre for Causal Analyses in Translational Epidemiology, Department of Social Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol, United Kingdom; 3Institute for Cancer Studies, University of Sheffield, G Floor Medical School, Beech Hill Road, Sheffield, United Kingdom; 4Department of Oncology, University of Cambridge, Addenbrooke's Hospital and 5Cancer Research UK Genetic Epidemiology Unit, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge, United Kingdom; 6Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, Headley Way, Headington, Oxford, United Kingdom; 7deCODE genetics and 8Department of Pathology, Landspitali-University Hospital, 101 Reykjavik, Iceland; 9The Institute of Cancer Research and 10The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK Professor Emeritus of Surgical Oncology, Universities of Cambridge and Oxford, UK. Electronic address: [email protected]. Uro-oncology Research Group, CRUK Cambridge Institute, Cambridge, UK; Department of Urology, University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK Authors' Affiliations: 1Postgraduate Medical School, Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom; 2St. George's, University of London, London, United Kingdom; 3Royal Surrey County Hospital, Guildford, United Kingdom; 4Uro-Oncology Research Group, CRUK Cambridge Research Institute, Cambridge, UK; 5Basingstoke Hospital, Basingstoke, United Kingdom From the Department of Urology and University Department of Surgery, Freeman Hospital, Newcastle upon Tyne, England Department of Oncology, University of Cambridge, Cambridge, United Kingdom; 33Department of Oncology, University of Cambridge, United Kingdom. Uro‐Oncology Research Group, Department of Oncology, University of Cambridge, Cancer Research UK Cambridge, Research Institute, Li Ka Shing Centre Robinson Way Cambridge CB2 0RE UK Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom. Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom. Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, United Kingdom. Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, Cambridge, UK; Department of Surgical Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. Department of Oncology University of Cambridge Cambridge UK Northern Institute for Cancer Research, School of Surgical and Reproductive Sciences, Faculty of Medical Sciences, University of Newcastle, Newcastle-Upon-Tyne, United Kingdom Department of CRUK CRUK Cambridge Institute University of Cambridge Cambridge UK From the University Departments of Surgery and Urology, Freeman Hospital, Newcastle upon Tyne, United Kingdom Nuffield Department of Surgical Sciences University of Oxford Oxford UK Uro‐oncology Research Group Cancer Research UK (CRUK) Cambridge Institute Cambridge UK; Department of Urology University of Cambridge, and S4, Department of Oncology, Addenbrooke's Hospital Cambridge UK Authors' Affiliations: 1MRC Centre for Causal Analysis in Translational Epidemiology, 2School of Social and Community Medicine, University of Bristol, Bristol; 3Nuffield Department of Surgical Sciences, John Radcliffe Hospital, University of Oxford, Oxford; and 4Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK Authors' Affiliations: 1Department of Social Medicine and 2Medical Research Council Centre for Causal Analysis in Translational Epidemiology, Department of Social Medicine, University of Bristol, Bristol, United Kingdom; 3Department of Physiology, Anatomy and Genetics and 4Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom; 5Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway; 6Health Protection Agency, London, United Kingdom; 7Department of Heart Disease, Haukeland University Hospital and 8Institute of Medicine, University of Bergen, Bergen, Norway; 9Department of Heart Disease, University Hospital of North Norway, Tromsø, Norway; 10Departments of Medicine and of Community and Family Medicine, Dartmouth Medical School, Lebanon, New Hampshire 03766; and 11Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Department of Oncology, University of Cambridge, Cambridge, UK 1Cancer Research UK Cambridge Research Institute; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, England. Department of Oncology, Addenbrooke's Hospital, University of Cambridge, England. University of Cambridge, Department of Oncology, Box 279 (S4) Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK Julia Wade, Rhiannon C. Macefield, Kerry N.L. Avery, C. Elizabeth Salter, Jane M. Blazeby, J. Athene Lane, Chris Metcalfe, and Jenny L. Donovan, University of Bristol, Clifton, Bristol; Derek J. Rosario and M. Louise Goodwin, Royal Hallamshire Hospital, University of Sheffield, Sheffield; David E. Neal, University of Cambridge, Addenbrooke's Hospital, Cambridge; and Freddie C. Hamdy, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom. Prostate Research Group, Northern Institute for Cancer Research, Paul, O’Gorman Building, University of Newcastle Upon Tyne, Medical School, Framlington Place, Newcastle Upon Tyne NE2 4HH, UK and 1MRC Cancer Cell Unit, University of Cambridge, Cambridge CB2 2X2, UK Academic Urology Group, University of Cambridge, Cambridge, UK; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. Electronic address: [email protected]. Uro‐oncology Research Group CRUK Cambridge Institute Cambridge UK; Department of Urology University of Cambridge Cambridge UK; Department of Oncology Addenbrooke's Hospital Cambridge UK Nuffield Department of Surgery University of Oxford Oxford United Kingdom Department of OncologyAddenbrooke's HospitalUniversity of CambridgeCambridge United Kingdom Cambridge Research Institute Cancer Research, Cambridge, UK Nuffield Department of Surgical Sciences University of Oxford Oxford UK; Academic Urology Group University of Cambridge Cambridge UK University of Cambridge. 3University Department of Oncology, Addenbrooke's Hospital, Cambridge, United Kingdom. Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK; Department of Urology, Addenbrooke's Hospital, Cambridge, UK Uro‐oncology Group Cancer Research UK Cambridge Institute Cambridge United Kingdom From the Department of Surgery, Medical School, University of Newcastle, and Departments of Urology and Anaesthesia, Freeman Hospital, Newcastle upon Tyne, England. Prostate Research Group School of Surgical and Reproductive Sciences Medical School, University of Newcastle upon Tyne Newcastle upon Tyne, England NE2 4HH Academic Urology Group Department of Surgery University of Cambridge Cambridge UK Uro-Oncology Research Group, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, UK; Dept of Urology, University of Cambridge, S4, Dept of Oncology, Addenbrooke's Hospital, UK Cancer Research UK Cambridge Research Institute Department of Uro‐oncology Addenbrooke's Hospital Cambridge UK Nuffield Department of Surgery University of Oxford Oxford UK From the University Department of Surgery and Department of Clinical Oncology, University of Newcastle upon Tyne, and Departments of Urology and Pathology Freeman Hospital, Newcastle upon Tyne, England From the Department of Urology, University Department of Surgery and Regional Medical Physics Department, Freeman Hospital, Newcastle upon Tyne, England University Department of Oncology, Addenbrooke's Hospital, University of Cambridge, UK. 1Uro-Oncology Research Group, Cancer Research UK, Cambridge Research Institute and Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge, CB2 2QQ, UK From the Departments of Urology and Medical Physics, Freeman Hospital, and University Department of Surgery, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom Department of Urology Addenbrooke's University Hospital Cambridge UK Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK; Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. 17Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom.; 18Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, United Kingdom. University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge. Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. 4The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey and London;; 6Department of Oncology, University of Cambridge, Cambridge; From the Department of Urology and University Department of Surgery and Department of Pathology, Freeman Hospital, Newcastle upon Tyne; The University Department of Pathology, University of Newcastle upon Tyne, ICRF Molecular Immunochemistry Laboratory, Potter’s Bar, Herts; The Institute of Molecular Medicine, John Radcliffe Hospital, Oxford Department of Oncology, University of Cambridge, Cambridge, UK Addenbrooke's Hospital; Box 193 Hills Road Cambridge UK CB2 2QQ Prostate Research Group, Department of Surgery, The Medical School, University of Newcastle, Newcastle upon Tyne, NE2 4HH, UK Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. University Department of Surgery, Martin Wing, The General Infirmary, Leeds LS1 3EX Departments of Urology and Medical Physics, Freeman Road Hospital, and University Department of Surgery, Medical School, Newcastle Upon Tyne, England. Authors' Affiliations: 1School of Social and Community Medicine, University of Bristol, Bristol, UK; 2MRC Center for Causal Analyses in Translational Epidemiology, School of Social and Community Medicine, University of Bristol, Bristol, UK; 3Nuffield Department of Surgery, University of Oxford, Oxford, UK; 4Department of Oncology, University of Cambridge, Cambridge, UK; 5Norwich Medical School, University of East Anglia, Norwich, UK; 6McGill University-Genome Quebec Innovation Centre, Montreal, Canada 1Cancer Research UK Uro-Oncology Research Group, Department of Oncology, University of Cambridge, Hutchison/Medical Research Council Cancer Research Centre, Cambridge CB2 2XZ, England, UK Nuffield Department of Surgical Sciences, John Radcliffe Hospital, Oxford, UK. Department of Oncology, Addenbrooke’s Hospital, University of Cambridge; Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK CRUK Cambridge Research Institute; Cambridge UK Department of Uro‐Oncology University of Cambridge Cambridge UK Department of Surgery, School of Surgical Sciences, Medical School, University of Newcastle, Newcastle upon Tyne NE2 4HH, UK Cancer Research UK Cambridge Institute, University of Cambridge, CB2 0RE Cambridge, UK; Department of Oncology, Addenbrooke’s Hospital, CB2 2QQ Cambridge, UK 1Uro-Oncology Research Group, Cambridge Research Institute, Cambridge, United Kingdom.; 9Department of Urology, Addenbrooke's Hospital, Cambridge, United Kingdom.; 10Department of Oncology, University of Cambridge, Cambridge, United Kingdom. University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, United Kingdom. Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, United Kingdom. Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Headington, Oxford, UK; University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. Uro‐Oncology Research Group Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Cambridge UK; Department of Urology Addenbrooke's Hospital Cambridge UK; Department of Oncology University of Cambridge Cambridge UK Cambridge University and Cambridge University Hospitals NHS Trust, Cambridge, UK. Authors' Affiliations: 1MRC Centre for Causal Analysis in Translational Epidemiology, 2School of Social and Community Medicine, 3School of Clinical Sciences North Bristol, University of Bristol, Bristol; 4Nuffield Department of Surgical Sciences, John Radcliffe Hospital, Oxford; 5Department of Oncology, University of Cambridge, Cambridge; and 6Department of Health Sciences, University of York and the Hull York Medical School, York, United Kingdom Department of Oncology, Cambridge University, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge CB2 0RE, U.K. From the Department of Urology and University Department of Surgery, Freeman Hospital, Medical Statistics Department and University Department of Pathology, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom Authors' Affiliations: 1Epidemiology Program, University of Hawaii Cancer Center, University of Hawaii, Honolulu, Hawaii; 2Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California; 3Department of Biostatistics, University of Washington, Seattle, Washington; 4Genetic Analysis Platform and Program in Medical and Population Genetics, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Laboratories for 5Biomarker Development and 6Statistical Analysis, Center for Genome Medicine, RIKEN; 7Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo; 8Laboratory for Genotyping Development, Center for Genome Medicine, RIKEN, Yokohama, Japan; 9Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Laboratory, Worts Causeway, 10Department of Oncology, University of Cambridge, Cambridge; 11Nuffield Department of Uro-Oncology Research Group, Cancer Research UK Cambridge Research Institute, Robinson Way, Cambridge, CB2 0RE, UK Uro-Oncology Research Group, Cancer Research United Kingdom, Cambridge Research Institute, Cambridge CB2 0RE, United Kingdom; and Oncology Centre, Addenbrooke’s Hospital, University of Cambridge, Cambridge CB2 0QQ, UK. Authors' Affiliations: 1Laboratory of Molecular Medicine, Human Genome Center; 2Division of Clinical Immunology, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Shirokanedai, Minato-ku, Tokyo; 3Department of Surgery and Science, Graduate School of Medical Science, Kyusyu University, Maidashi, Higashi-ku, Fukuoka; 4Laboratory for Medical Informatics, RIKEN, Suehirocho, Tsurumi-ku, Yokohama, Kanagawa, Japan; 5Department of Oncology, Cancer Research UK Cambridge Research Institute; 6Department of Genetics, University of Cambridge; and 7Division of Surgery & Interventional Science, UCL Medical School, University College London, London, United Kingdom |
Incoming Links
Showing number of triples: 1 to 481 of 481.